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Liposomal drug delivery (LDD) is a rapidly expanding 
area of pharmaceutical research that holds the great 
promise for targeted drug delivering & has become a 
fertile topic of research currently.LDD seems to be 
attractive compared to conventional dosage forms 
because of the innovative ride taken up by the 
pharmaceutical technologist in the formulation, which is 
not going to be that easy as there are issues like stability, 
efficacy & toxicity have to be considered. So far several 
studies focused on efficacy & stability of the 
formulations which is of course important but today the 
toxicity profile has become a serious consequence which 
leads to unsparing effect on life. Despite a wealth of data 
is available on both the stability & efficacy of liposomes 
and the toxic nature & their physicochemical interaction 
with cellular components is still scarce. In the view of 
recent findings, apart from the pharmacological actions 
cationic liposome’s have profound toxic effects like 
emboli, platelet aggregation, haemolysis, immune 
response, neurotoxicity etc, which might be due to 
interactions of liposome with cellular components. LDD 
for cancer therapy was found to be effective but the 
toxicity addressed is still an obstacle i.e. drugs like 
doxorubicin encapsulated in very high concentration in 
liposomes shown cardio toxicity & skin toxicity1. 
Causes of toxicity: 
 Liposomal components 
The composition of lipid formulations can be carefully 
tailored, because chronic administration of liposomes 
can induce toxicity dependent on composition. For 
instance, one frequently used lipid formulation deals 
with the incorporation of cationic lipids in liposomes to 
improve cellular uptake of the particles. Therefore, it is 
necessary to study the nonspecific effects associated 
with the particular composition and other properties of 
liposomes should be carefully considered during 
ABSTRACT 
Liposomal drug delivery (LDD) has become a promising strategy & is continuing to be a big success for the Pharmaceutical 
Industry. Toxicity associated with LDD did not pin point intricately making it impossible to construe. Although the induction 
of Liposomal toxicity is mysterious & there has been a limited exploration, there was some evidence from animal studies 
which include haemolysis platelet aggregation, emboli, seizures & ‘proton sponge effect’. The mechanism responsible for 
induction of immune responses is revealed by protein kinase-C mediated down regulation of TNF-α, NO, PGE-2. Reports at 
the molecular level has been proved that Liposomal efficiency/ toxicity profile was influenced by factors like molecular weight, 
ionic strength particle size & the amount of drug load into the liposome i.e., anticancer drug loaded excessively into liposome 
has lead to cardio toxicity, skin toxicity. Increased concentration of drug hampered the efficiency due to crystalline formation 
& altered rate kinetics of drug release. The present objective of the study is to signify the causes of toxicity & attempts to wipe 
out the harmful effects associated with LDD. The task of minimizing the toxic effects of LDD is challenging aspect  for the 
pharmaceutical technologist & makes this novel drug therapy safe, effective & unblemished. 
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formulation. 
Although phospholipids themselves are generally non 
cytotoxic, cationic lipids, like 1, 2-dioleoyl-3-trimethyl 
ammonium propane (DOTAP) which is a well known 
cationic lipid in DNA transfection procedures, have been 
described to damage cellular physiology 2.The degree of 
haemolysis depended on the concentration and the type 
of phospholipids used in the formulation. Negatively 
charged DSPG (Distearoyl phosphatidyl glycerol)- 
liposomes induced a small but reversible platelet 
aggregation. These liposomes also affect the coagulation 
cascade, which shows prolonged coagulation times. 
Cationic liposomes may be useful in the treatment of a 
number of diseases, including DNA delivery for gene 
therapy. But have higher toxic effects than neutral & 
anionic because they are highly fusogenic & have 
highest transfection activity3. 
Example: DOPE: cholesterol: DC-C-14(3:3:4)
 
Table 1: Differences in toxicity between different Liposome types 










PC:Chol ++++ Unknown + +++ ++++ 
PC:Chol ++ Unknown + ++++ ++++ 
DPPC:Chol +++ Unknown +++ ++ +++ 
Card:PC:Chol:SA +/- + ++ ++ + 
PG:PC ++ + + ++ ++ 
PC: phosphotidyl choline; SA: stearylamine; DPPC: d ipalmitoylphosphatidylcholine 
 
The correlation between the net Liposomal charge and 
toxicity is unambiguous. At the present, the 
mechanism(s) for these toxic effects are not Known, but 
thought to be mediated directly at the cell surface. 
Neutral DPPC: chol and PC: chol liposome were 
nontoxic, whereas neutral card: PC: chol: SA Liposomes 
were as toxic as the positive SA: PC: chol liposome. 
Stearyl amine liposomes with blood cells induced cell 
lysis 4.  
Lipid structure vs. toxicity 
Cationic lipids used for LDD are composed of three 
basic domains: A positive charged head group often 
consists of primary, secondary, tertiary amines or 
quaternary ammonium salts, cytotoxic effect associated 
with the lipid formulation is mainly determined by the 
structure of its hydrophilic group. A linker joins the 
polar and non-polar regions, most of that in the lipids are 
ether, ester or amide bond. Although compounds with 
ether linker render better transfection efficiency, they are 
too stable to be biodegraded thus cause toxicity, finally a 
hydrophobic chain5. 
Example: The three basic domains of 1, 2-dioleoyloxy- 
3-trimethylammonium propane (DOTAP). The polar and 
hydrophobic domains of cationic lipids may have 
dramatic effects on both the transfection and toxicity 
levels.  
Various studies found that toxicity of liposomes is 
associated with type of lipid used in formulation of 
liposomes & few are depicted as follows: There are two 
major types of hydrophobic moieties, namely aliphatic 
chains and cholesterol-based derivatives. In general, for 
aliphatic chains, single-tailed cationic lipids are more 
toxic and less efficient than their double-tailed 
counterparts.6- lauroxyhexyl ornithinate (LHON) with 
one tail was more efficient & of lower cytotoxicity 
compared with DOTAP6.  
Cationic amphiphiles containing steroid back bone were 
more potent inhibitors of PKC than their straight chain 
analogues; therefore they had higher toxicity profiles7. 
Cetyl trimethylammonium Bromide (CTAB) was more 
toxic and less efficient than DOTMA (dioleyl tri methyl 
ammonium)8. The obvious difference between cationic 
polymers and cationic lipids is that they do not contain a 
hydrophobic moiety and are completely soluble in water 
9. Compared with cationic liposomes, they have the 
absolute advantage of compressing DNA molecules to a 
relatively small size10.This is most useful in gene transfer 
as small particle size may be favorable for improving 
transfection efficiency11. Modifications to these 
polymers such as molecular weight, geometry (linear vs. 
branched) and ligand attachment can be easily achieved, 
so that the out comes from such modifications can be 
extensively used for the formulation by conducting 
structure/function relationship studies.  
For example, Polyethylenimine (PEI), a commercially 
available cationic polyamine is one of the most 
successful and widely used as gene delivery polymers. 
There are mainly two types of structure: Linear molecule 
and branched molecule. PEI is a gene carrier with high 
transfection efficiency and high cytotoxicity 12. Many 
factors affect the efficiency/cytotoxicity profile of PEI 
such as molecular weight, degree of branching, ionic 
strength of the solution, zeta potential and particle size 
13. One study, as an exemplary, showed that low 
molecular weight (10 k Da), moderately branched 
polymer resulted in efficient delivery with low toxicity 
when compared with high molecular weight 
commercially available PEI. Cationic lipids are usually 
used in association with dioleyol phosphatidyl 
ethanolamine (DOPE) to deliver nucleic acids inside 
mammalian cells for gene therapy14. 
The rank order of toxicity profiles for some lipids was as 
follows:  
DOPE/DDAB > DOPE/DOTAP > DOPE/DMTAP > 
DOPE/DPTAP > DOPE/DSTAP. 
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DOPE :( Dioleoylphosphatidylethanolamine); DDAB ( 
Dioleyl diacyl ammonium bromide)DOTAP :( Di oleyl 
tri methyl ammonium propane); DMTAP: (dimethyl di 
oleyo diacyltrimethylammonium propane); DPTAP 
(dipalmitoyl- diacyltrimethyammonium propane); 




Three Novel galactosylated cholesterol derivatives, such 
as cholesten-5-yloxy- N-(4-((1-imino-c-β-D-
thiogalactosyl-ethyl) amino) butyl) formamide (Gal-C4-
Chol) and its ethyl formamide and hexyl formamide 
analogues (Gal-C2-Chol, Gal-C6-Chol) were 
synthesized by Liposome/DNA complexes prepared with 
these lipids showed low cytotoxicity in human hepatoma 
Hep G2 c therefore different reagents have different 
degrees of toxicity to cells, and toxicity is cell-specific 
15. 
The influences of liposomal phospholipid composition 
on the activity of incorporated immunomodulatory drugs 
have so far been assumed to be relatively unimportant 
because of the presumed inert nature of phospholipids 
towards the immune system16. There is, however, ample 
evidence of intrinsic immunomodulatory activity for 
several phospholipids. For example, phosphatidyl serine 
has been shown to stimulate macrophage growth 17 and 
to inhibit the production of IL-2 and IL-2 receptor 
expression in T-lymphocytes 18 while 
phosphatidylethanolamine can stimulate the synthesis of 
prostaglandin E2 by macrophages 19.  
One of the significant factors was observed; that is the 
charge, which is negatively correlated to the sensitivity. 
Positive charge was defined as high level which means 
positively charged liposomes reduces the sensitivity 
value and consequently is more toxic than negatively 
charged liposomes. It has been reported that polycations 
such as polylysine, polyhistidine and polymyxin B cause 
aggregation, fusion and lysis of the membranes. The 
liposomes bound with these polycations would act as the 
membrane-damaging agents. The destabilization of the 
endosomic membrane and subsequently release of 
cationic lipid into the cytoplasm is necessary for the 
induction of toxicity which clearly confers that 
liposomes must be internalized to induce toxicity 
20
. The 
liposome protects the drug from metabolism & reduces 
the extent of drug accumulation in healthy tissues 21 
there by low level of adverse effects. However, Drugs 
loaded in liposomes in higher concentration hampers the 
drug efficacy because of reduce concentration of drug at 
tumor site & altered rate kinetics of drug. Molecular 
mechanism reveals that higher concentration of drugs in 
liposomes forms larger size vesicles that reduce the 
membrane stability of the cells due to electronic 
interactions 22.  
One such case of drug formulation is LDOX (Liposomal 
doxorubicin), LDOX is a powerful mutagen, embriotoxic 
& induces long term sterility. The evaluation of 
reproductive toxicity was restricted to fertility studies, 
since there were data on the embryo toxic and 
teratogenic nature of doxorubicin HCl, as well as on its 
ability to induce long-term or permanent sterility, also 
involve in shrinking of cells by vacuolizing the 
cytoplasm. A high dose of cationic lipids increase 
electrostatic interactions with plasma membrane results 
in cytotoxicity & is inadequate for therapeutic 
application. Data on the haemolytic potential of LDOX 
submitted showed that they caused haemolysis of human 
RBCs or coagulation or precipitation of human serum or 
plasma. One of the most significant toxicities for LDOX 
is a condition consisting of dermal lesions referred to as 
H-F syndrome (Hand and Foot syndrome)23,24. This same 
condition was previously described in patients receiving 
long continuous infusions of 5- fluorouracil, DOX.
 
Table 2: Various toxicities associated with free doxorubicin and LDOX 
Free doxorubicin HCL LDOX ( liposomal formulation) 
a) Cardiac toxicity Reduced or not observed 
b) Myelosuppression Reduced (to a greater extent with SSLs) 
c) Mucositis Slightly increased with Doxil 
d) Alopecia Reduced or not observed 
e) Severe local tissue necrosis 
after drug extravasations 
Observed  with Doxil  or  with continuous infusion of free DOX 
f) nausea & vomiting Reduced or not observed 
g) H-F syndrome Observed  with Doxil  or  with continuous infusion of free DOX 
 
The toxicities represented in table 2 are thought to be 
due to the inability of liposomes to cross the endothelial 
cell barrier in the tissues and the low bioavailability of 
the free drug due to its encapsulation in liposomes. 
Indeed, in tissue sections of cardiac muscle, liposomes 
are found exclusively in the blood vessels and not in the 
muscle fibers suggesting that most of the drug is not 
bioavailable in the myocardium. Positively charged 
liposomes like stearylamine were reported to enhance 
the permeability of biomembranes and damage the cells. 
DC-6-14 liposomes can interact with plasma proteins 
and blood cells, leading to a gradual Liposomal lysis. 
However hemolytic activity of DC-6-14 liposomes was 
weaker than that of stearylamine-containing liposomes. 
Cationic lipids have longer times, escape from liver 
uptake & show specific receptor site of action. Shrinking 
of cells reduced no of mitoses & vacuolization of the 
cytoplasm are the unidentifiable effects, where as DC-6-
14 Liposomes don’t circulate accumulate in lung after 
administration leads to liver uptake.  
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Furthermore, it was reported that the use of cationic 
liposomes to target DNA to the gastrointestinal tract is 
inappropriate & also Cationic DOPE: DOTAP liposomes 
are extremely toxic to CD1 (mice) on the administration 
of a single dose, provoking a profound and lethal 
hypothermia. Hence, Cationic lipids with heterocyclic 
rings shown low le vel of toxicity & would be worth for 
in vivo delivery of drugs. Tertiary analogues of DOTAP 
(dioleoyl trimethylammonium propane) DODAP( 
dioleoyl-diacyltrimethylammonium propane) did not 
induce inflammation but histological assays revealed 
mild toxicities in muscle cells.di-c-14 amidine up 
regulated CD80,CD86 membrane expression of 
cytokines &interferes with cell signaling path way. The 
uptake of liposomes in cells involves binding of the 
liposomes to the cell surface followed by endocytosis. 
Different cells vary with their ability to take up 
liposomes and thereby by their sensitivity towards the 
Liposomal formulation. It seems possible that at least 
some of the toxic effects of liposomes are mediated 
directly at the cell surface, especially for cells which are 
not strongly endocytotic. The usage of neutral lipids 
allows one to decrease toxicity and attain higher 
transfection levels in vivo which may be determined by 
their special structures. For instance, DOPE can facilitate 
membrane fusion and aid the destabilization of the 
plasma lemma or endosome. 
Mechanism: 
The mechanism of induction of toxicity has a limited 
exploration. Further data from the research have yet to 
be elucidated. Lipids are not just carriers for the drug 
delivery but do modify cellular path ways & stimulate 
anti inflammatory responses especially cationic 
lipids[25]. Ex: poly cationic sphingolipid shown strong 




Figure 1: Representation of Mechanism of Cationic liposomes or components recognize G-protein couple receptor and activates 
MAPK (Mitogen activated protein kinases through PI-3 kinase and induce the expression of chemokines in dendritic cells, via Ap-
1(Activator protein). In general signalling pathways of MAPKs transduce extracellular stimuli to altered gene expression resulting in 
cell proliferation, differentiation and apoptosis mediated by ERK (Extracellular Signal Regulated Kinase), JNK (C Jun amino- 
terminal kinase) and P38 kinase. Cationic liposomes activate phospholipase C, thereby increase the intracellular calcium and IP-
3(Inositol triphosphate) levels and stimulate the MAPK’s, or directly gets inserted into the plasma membrane and can alter the 
membrane proteins function. Liposomes containing amide and amine groups can stimulate the dendritic cells through their 
interaction with TLR (Toll like receptor) and activates a series of proteins i.e., MYD88 (Myeloid differentiation protein) IRAK 
(Interleukin-1 receptor associated kinase), TRAF ( Tumor necrosis factor associated kinase) and IKK(Ik-B kinase) which are 
involved in the synthesis of nuclear transcription factor NF-kB(Nuclear factor kappa light chain enhancer of activated B cells) that 
involves in production inflammatory mediators like Interleukins, TNf-α etc further gets recruited by macrophages at the site of tissue 
damage and ultimately worsens the damaged tissue. 
 
Krishna et al                                       Journal of Drug Delivery & Therapeutics; 2014, 4(4), 137-144 141 
© 2011-14, JDDT. All Rights Reserved                                                 ISSN: 2250-1177                                               CODEN (USA): JDDTAO 
Proton sponge effect: Amine groups present in lipids 
gets protonated by the addition of protons pumped into 
lysosomes together with chloride ions to maintain charge 
neutrality results in higher ionic strength of lysosomal 
matrix followed by osmotic swelling & rupture of 
lysosomes. The release of lysosomal enzymes & acidic 
contents leads to cell death 26.
 
 
Figure 2: Cationic (for example PEI-coated) particles bind with high affinity to lipid groups on the surface membrane and are 
endocytosed into the cell. When a liposomal component interacts with cell membrane due to oxidative stress it generates Reactive 
Oxygen Species (ROS) which in turn has effects on the cell organelles. Once these cationic particles enter into an acidifying 
lysosomal compartment, the unsaturated amino groups are capable of sequestering protons that are supplied by the v-ATPase 
(proton pump) on the lysosomes. This process keeps the pump functioning and leads to the retention of one Cl- ion and one water 
molecule per proton. Subsequent lysosomal swelling and rupture leads to spillage of the lysosomal content into the cytoplasm. 
Cathepsins are the components of lysosomes which can amplify the apoptotic signals by degradation of antiapoptotic factors like Bcl 
(B-Cell Lymphoma) and promoting the cleavage of Bid. Cleaved Bid gets translocated into mitochondria via bax which is a 
proapoptotic factor. As a consequence procaspases activated into caspases in mitochondria leads to cell death. ROS alters the 
transcription in the nucleus and produces proinflammatory mediators which have profound effect on cells. 
 
The  toxicity  and  the  immunomodulatory  activity  of  
different  cationic  lipids  toward macrophages and T- 
lymphocytes have been evaluated. Some of the lipids, 
such as derivatives of cholesterol, are protein kinase C 
(PKC) inhibitors, which may be associated with their 
own profile of  toxicity i.e., Cationic amphiphiles 
containing steroid backbones were more potent 
inhibitors of PKC than their straight-chain analogues, 
therefore they had higher toxicity too. Cationic amphillic 
compounds can inhibit PK-C activity results in down 
regulation of NO, PGE-2, TNF-α. The fact that cationic 
liposomes are highly toxic toward macrophages but not 
toxic toward T lymphocytes was explained by the 
enhanced relative phagocytic activity of macrophages 
compared to T cells. Toxicity and down regulation of 
NO and TNF- α was related to the presence of cationic 
lipid and was enhanced by DOPE 
(Dioleoylphosphatidylethanolamine) & Dc-Chol 
(dimethyl aminoethanecarboyl– cholesterol). 
Cationic liposomes down regulated NO, TNF-α and 
PGE2 synthesis which has been proved from the 
experimental studies like incubation of macrophages 
with DOPE: DOTAP and DC: Chol resulted in reduction 
of macrophages. The mechanism by which liposomes 
results in loss of cell integrity and cell death might be the 
same, the initial adherence of the formulation to the cell 
surface which may be of greater importance for the 
toxicity in cells that are less phagocytic in nature. The 
toxicity toward macrophages indicates that the cationic 
liposomes must be internalized to induce toxicity. The 
replacement of DOPE by non- fusogenic DPPC lipids  
also  abolished  this  toxicity,  indicating  that  the  
destabilisation of  the  endosomic membrane and 
subsequently release of cationic lipid into the cytoplasm 
is necessary for the induction of toxicity.
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Reported adverse effects associated with the use of cationic lipids or Cationic liposomes 
2 
In vitro toxicities In vivo toxicities 
Induction of chromosome aberrations in human 
culture cells 
Induction of eyes inflammation in rabbits when instilled intra-
ocularly 
Induction of haemolysis Affects  immune  response to antigens  in mice, dependence upon 
type of antigen, dose and time of administration 
Inhibition of the respiratory burst of neutrophils Neurotoxic after i.c. injection; produces epileptic seizure and 
death in mice 
Enhanced superoxide production by neutrophils Activation  of  complement  via  the  alternative pathway 
Inhibition of PKC activity Toxic  when administered  intra-articularly  into knee joints 
Toxic for non-phagocytic cells Induction  of  acute  pulmonary  inflammation reaction 
Down-regulation of the production of IgG and IgM 
by human peripheral blood  mononuclear cells 
Induction of emboli after i.v. injection 
Aggregation of cationic liposomes by albumin, IgG 
or salivary glycosaminoglycan 
Highly   toxic   when   administered   orally; provoking a 
profound and lethal hypothermia 
Highly toxic for phagocytic cells Down-regulation  of  NO,  TNF-a  and  PGE2 synthesis 
Down-regulation  of  NO,  TNF-a  and  PGE2 
synthesis 
Strong anti- inflammatory activity in carrageenan and   in   sheep   
red   blood   cell   challenge inflammatory models 
Inhibition of DNase activity Induction of anti-single strand DNA antibodies 
Inhibition of DNase activity Induction of anti-single strand DNA antibodies 
 
Formulation factors behind the toxicity: 
When formulating liposomes the choice of main lipid, 
the choice of charged component, and the amount of 
charged component in the liposomes are important issues 
and have to be considered to obtain Liposomal 
formulations with minimum toxicity. When formulating 
positively charged liposomes a low amount of charged 
lipid is favorable. DPPC 
(dipalmitoylphosphatidylcholine) seems to be the best 
choice as the main lipid. 
Liposomal dose: High lipid doses bind to endogenous 
lipids results in the interactions may result in toxicity 
i.e., of two types27,28. Immediate due to interaction with 
the plasma proteins majorly with albumin and delayed 
due to clusters of RBC adhere to cell surface & 
destabilize the plasma membrane. 
Drug loading: Drugs loaded in liposomes in higher 
concentration hampers the drug efficacy because of 
reduced concentration of drug at tumor site & altered 
rate kinetics of drug. LDOX (Liposomal doxorubicin) is 
a power full mutagen, embryo toxic & induces long term 
sterility, also involve in shrinking of cells & vacuolizes 
the cytoplasm. 
Liposomal size: Larger vesicles containing higher 
amount of drugs reduces the membrane stability of the 
cells due to electronic interactions which leads to 
toxicity. It was also proven that SUV were more toxic 
than MLV. Diameter does not influence toxic profile 
significantly. 
Method of sterilization: Liposomes composed of 
unsaturated phospholipids revealed toxic effects on the 
cell line, and their toxic effects were increased after 
gamma irradiation. Liposomes composed of saturated 
phospholipids did not show any toxic effects, and form 
safety & drug delivery point of view, gamma irradiation 
is an appropriate sterilization method for them. 
Few recent findings to conquer problems associated 
with LDD: 
Solutions proposed to surpass the toxicities by making 
use of biodegradable polymers, saturated oleic lipid 
chains, complexation of lipids with DNA adjusting 
physical properties, dose, and composition of carriers. It 
has been reported that modifying the molecular structure 
of lipids and other components made their utilization in a 
safe manner. Biomaterials because of their non-toxic and 
enzymatically biodegradable properties, like 
Carboxymethyl chitin (CM-chitin) has been used to 
stabilize liposomes composed of phosphatidylcholine 
(PC) ,CM-chitin will bound to the surface of the 
liposomes, thereby strengthening the liposomes and 
increasing their stability29. Neutralizing the charge of 
cationic lipid & certain alterations in the molecular 
structure of lipids has made their utilization more 
feasible. Cationic lipids with heterocyclic rings show 
low level of toxicity & would be worth for in vivo drug 
delivery. The replacement of DOPE by DPPC reduced 
cationic liposomes toxicity toward macrophages and the 
use of DPPE-PEG2000 abolished toxicity by blocking 
liposomal endocytosis 30. It was suggested that i.v 
injected DC-6-14 aggregates with blood cells & these 
aggregates were trapped in lung capillaries temporarily 
as the liposomes left the lung, aggregates breakage might 
occur. Interaction between cells & liposomes might be 
relatively weak as to induce degradation of aggregates in 
lung capillaries. Then blood cells & liposomes were 
redistributed gradually to blood stream & to liver. 
Glycolipid liposomes were suggested to be adsorbed on 
blood cell surface & escape liver uptake. Tertiary 
analogues of DOTAP (dioleyl-trimethylammonium 
propane) & DODAP (dioleyl diacyl ammonium propane) 
did not induce inflammation. Di-c-14 amidine up 
regulated CD 80, CD86 membrane expression of 
cytokines & interferes with cell signaling path way. 
Galactosylated cholesterol derivatives were used in 
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Liposomal / DNAcomplexes showed significantly less 
cytotoxicity compared to the commonly used cationic 
liposomes 31. 
Detoxification of Liposomal doxorubicin (LDOX) by 
double filtration in-vitro plasmapheresis Liposomes 
composed of unsaturated phospholipids revealed toxic 
effects on the cell line, the liposomes became more 
negatively charged after irradiation due to the presence 
of charged degradation products by undergoing 
peroxidation. Liposomes composed of saturated 
phospholipids did not show any toxic effects, and from 
safety and drug delivery point of views, gamma 
irradiation is an appropriate sterilization method for 
them. 
CONCLUSION: 
It is apparent that potential non specific effects 
associated with particular composition & other 
properties of liposomes should be carefully assessed. 
This problem is likely to intensify the risk factor 
involved in formulation. Though much has been said 
about LDD things have so far not been turned out as 
expected, if they could be carefully handled by 
technologist, which might further attain higher success 
rate & better results so that LDD becomes appreciable in 
drug targeting. Cationic liposomes for DNA therapy 
should be considered in order to avoid these dose- 
limiting and often fatal adverse effects associated. 
Hence, it is note worthy that pharmaceutical technologist 
should pay keen attention & inculcate the appropriate 
selection of lipid components which may open new 
avenues in attempts to design LDD for targeting. This 
could be required not only for minimizing toxic effects 
but also adequate for therapeutic effect.
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